The primary objective of this clinical trial is to evaluate the safety of autologous engineered corpora cavernosa + albuginea constructs for treatment of comple...
Why does the clinical trial for this still languish?
This has been a trial in progress since 2018, so human trials have been backlogged for 5 years now.